Introduction: Cervical cancer (ICD-10: C53), though highly preventable, continues to pose a serious public health challenge in Brazil. As the third most common cancer among Brazilian women, with approximately 16,000 new cases annually (INCA 2023). Objectives: This study analyzes mortality trends (2010-2023) among regions, age groups, and race/ethnicity to inform policy. Methods: Ecological study using secondary data from Brazil's Mortality Information System (SIM/DATASUS) for women aged 20-70+. Results: The analysis of cervical cancer mortality in Brazil (2010-2023) revealed 84,794 recorded deaths, with striking regional disparities: the Southeast accounted for 28,052 deaths (33.1%), followed by the Northeast with 26,555 (31.3%), while the South, North, and Central-West regions represented 14.5%, 13.2%, and 7.9% of cases respectively. Notably, the Northeast's mortality burden is disproportionately severe when considering population distribution. Age-specific patterns showed peak mortality among 50-59 year-olds (18,454 deaths, 21.8%) and women over 70 (19,756 deaths, 23.3%), contrasted with significantly lower rates in younger groups (2,415 deaths in 20-29 year-olds, 2.8%). Racial disparities were particularly evident, with mixed-race women comprising 46.5% of deaths (39,389 cases) and Black women 8.1% (6,861 cases), collectively representing 54.6% of deaths. White women accounted for 34,942 deaths (41.2%), while Asian/Indigenous women represented 1% (831 cases), and 3.3% of records (2,771 deaths) lacked racial classification. These findings suggest three key patterns: the Northeast's elevated mortality likely reflects healthcare access barriers, the low mortality among women under 30 demonstrates HPV vaccine effectiveness (introduced 2014), while the high mortality in women over 50 reveals persistent gaps in screening implementation. The racial mortality disparities underscore socioeconomic vulnerabilities, though unclassified cases (3.3%) limit more comprehensive equity assessments. Conclusion: This study's documentation of persistent disparities in cervical cancer mortality offers critical insights for oncology practice and cancer control efforts in Brazil. The patterns observed—particularly the disproportionate burden among older women, mixed-race/Black populations, and Northeastern residents—reflect systemic challenges that extend beyond biological factors to reveal gaps in healthcare delivery. Closing these gaps demands integrating oncology and public health interventions that consider Brazil's complex regional and demographic landscape.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
